Differences between in vitro and in vivo genotoxicity due to metabolism: The role of kinetics

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Computational Toxicology

• Publication date

  2022-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.comtox.2022.100222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EURL ECVAM Genotoxicity and Carcinogenicity Database of Substances Eliciting Negative Results in the Ames Test: Construction of the Database

  2020cited by this paper
• Biological Basis for Threshold Responses to Methylating Agents

  2020cited by this paper
• Modeling hazard assessment of chemicals based on adducts formation. I. A basis for inclusion of kinetic factors in simulating skin sensitization

  2020cited by this paper
• In silico models for genotoxicity and drug regulation

  2020cited by this paper
• In silico model for mutagenicity (Ames test), taking into account metabolism

  2019cited by this paper
• Exposure source for skin sensitizing hydroperoxides of limonene and linalool remains elusive: An analytical market surveillance.

  2019cited by this paper
• Modified Ames test using a strain expressing human sulfotransferase 1C2 to assess the mutagenicity of methyleugenol

  2016cited by this paper
• Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens.

  2016cited by this paper
• A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?

  2015cited by this paper
• Exposure of mice to atrazine and its metabolite diaminochlorotriazine elicits oxidative stress and endocrine disruption.

  2014cited by this paper
• Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes.

  2012cited by this paper
• Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.

  2012cited by this paper
• Investigating the relationship between in vitro-in vivo genotoxicity: derivation of mechanistic QSAR models for in vivo liver genotoxicity and in vivo bone marrow micronucleus formation which encompass metabolism.

  2012cited by this paper
• MetaPath: an electronic knowledge base for collating, exchanging and analyzing case studies of xenobiotic metabolism.

  2012cited by this paper
• Simulation of chemical metabolism for fate and hazard assessment. V. Mammalian hazard assessment

  2012cited by this paper
• Simulation of chemical metabolism for fate and hazard assessment. I. Approach for simulating metabolism

  2011cited by this paper
• Substrate channeling and enzyme complexes for biotechnological applications.

  2011cited by this paper
• In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic

  2008cited by this paper
• OECD GUIDELINES FOR THE TESTING OF CHEMICALS

  2008cited by this paper
• Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test.

  2007cited by this paper
• OECD GUIDELINES FOR THE TESTING OF CHEMICALS

  2006cited by this paper
• Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitization.

  2004cited by this paper
• Three new consensus QSAR models for the prediction of Ames genotoxicity.

  2004cited by this paper
• Cyproterone acetate: a genotoxic carcinogen?

  2001cited by this paper
• The Ames Salmonella/microsome mutagenicity assay.

  2000cited by this paper
• OECD GUIDELINE FOR TESTING OF CHEMICALS Bacterial Reverse Mutation Test

  1999cited by this paper
• Toxicity and metabolism of malachite green and leucomalachite green during short-term feeding to Fischer 344 rats and B6C3F1 mice.

  1999cited by this paper
• A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.

  1994cited by this paper
• Pharmacokinetics of Salazosulfapyridine (Sulfasalazine, SASP). (III). Metabolism and biliary excretion of SASP in the rat after a single intravenous or oral administration.

  1991cited by this paper
• Comparison of in vivo and in vitro cytogenetic assay results.

  1986cited by this paper
• Salmonella mutagenicity test results for 250 chemicals.

  1983cited by this paper
• A METHOD FOR THE SOLUTION OF CERTAIN NON – LINEAR PROBLEMS IN LEAST SQUARES

  1944cited by this paper

• Boric Acid and Borax Protect Human Lymphocytes from Oxidative Stress and Genotoxicity Induced by 3-Monochloropropane-1,2-diol

  2024cites this paper
• The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment

  2023cites this paper
• Genotoxicity assessment of food-flavoring chemicals used in Japan

  2022cites this paper